Literature DB >> 27804264

Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes.

Patrick M O'Neil1, Karen Miller-Kovach2, Peter W Tuerk3,4, Lynne E Becker3, Thomas A Wadden5, Ken Fujioka6, Priscilla L Hollander7, Robert F Kushner8, W Timothy Garvey9,10, Domenica M Rubino11, Robert J Malcolm3, Daniel Weiss12, William J Raum13, Jonny L Salyer14, Kathie L Hermayer15, Stephanie L Rost2, Jan L Veliko2, Nicoleta D Sora15.   

Abstract

OBJECTIVE: Modest weight loss from clinical interventions improves glycemic control in type 2 diabetes (T2DM). Data are sparse on the effects of weight loss via commercial weight loss programs. This study examined the effects on glycemic control and weight loss of the standard Weight Watchers program, combined with telephone and email consultations with a certified diabetes educator (WW), compared with standard diabetes nutrition counseling and education (standard care, SC).
METHODS: In a 12-month randomized controlled trial at 16 U.S. research centers, 563 adults with T2DM (HbA1c 7-11%; BMI 27-50 kg/m2 ) were assigned to either the commercially available WW program (regular community meetings, online tools), plus telephone and email counseling from a certified diabetes educator, or to SC (initial in-person diabetes nutrition counseling/education, with follow-up informational materials).
RESULTS: Follow-up rate was 86%. Twelve-month HbA1c changes for WW and SC were -0.32 and +0.16, respectively; 24% of WW versus 14% of SC achieved HbA1c <7.0% (P = 0.004). Weight losses were -4.0% for WW and -1.9% for SC (Ps < 0.001). 26% of WW versus 12% of SC reduced diabetes medications (P < 0.001). WW participants had greater reductions in waist circumference (P < 0.001) and C-reactive protein (P = 0.02) but did not differ on other cardiovascular risk factors.
CONCLUSIONS: Widely available commercial weight loss programs with community and online components, combined with scalable complementary diabetes education, may represent accessible and effective components of management plans for adults with overweight/obesity and T2DM.
© 2016 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27804264     DOI: 10.1002/oby.21616

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  15 in total

1.  Financial implications of New York City's weight management initiative.

Authors:  Sagun Agrawal; Alexis C Wojtanowski; Laura Tringali; Gary D Foster; Eric A Finkelstein
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

Review 2.  Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; Vanita R Aroda; Billy S Collins; Robert A Gabbay; Jennifer Green; Nisa M Maruthur; Sylvia E Rosas; Stefano Del Prato; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Tsvetalina Tankova; Apostolos Tsapas; John B Buse
Journal:  Diabetologia       Date:  2022-09-24       Impact factor: 10.460

3.  Does weight management research for adults with severe obesity represent them? Analysis of systematic review data.

Authors:  Clare Robertson; Magaly Aceves-Martins; Moira Cruickshank; Mari Imamura; Alison Avenell
Journal:  BMJ Open       Date:  2022-05-31       Impact factor: 3.006

4.  Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; David A D'Alessio; Judith Fradkin; Walter N Kernan; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Apostolos Tsapas; Deborah J Wexler; John B Buse
Journal:  Diabetologia       Date:  2018-12       Impact factor: 10.122

5.  An online diabetes nutrition education programme for American Indian and Alaska Native adults with type 2 diabetes: perspectives from key stakeholders.

Authors:  Sarah Stotz; Angela G Brega; Steven Lockhart; Luciana E Hebert; J Neil Henderson; Yvette Roubideaux; Kelly Moore
Journal:  Public Health Nutr       Date:  2020-07-17       Impact factor: 4.022

Review 6.  Fad Diets: Hype or Hope?

Authors:  Aravind R Kuchkuntla; Berkeley Limketkai; Sanjeev Nanda; Ryan T Hurt; Manpreet S Mundi
Journal:  Curr Nutr Rep       Date:  2018-12

7.  Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and health equity in the adult population.

Authors:  Jennifer Petkovic; Stephanie Duench; Jessica Trawin; Omar Dewidar; Jordi Pardo Pardo; Rosiane Simeon; Marie DesMeules; Diane Gagnon; Janet Hatcher Roberts; Alomgir Hossain; Kevin Pottie; Tamara Rader; Peter Tugwell; Manosila Yoganathan; Justin Presseau; Vivian Welch
Journal:  Cochrane Database Syst Rev       Date:  2021-05-31

Review 8.  Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis.

Authors:  Chenhan Ma; Alison Avenell; Mark Bolland; Jemma Hudson; Fiona Stewart; Clare Robertson; Pawana Sharma; Cynthia Fraser; Graeme MacLennan
Journal:  BMJ       Date:  2017-11-14

9.  Behavior Change Techniques Included in Reports of Social Media Interventions for Promoting Health Behaviors in Adults: Content Analysis Within a Systematic Review.

Authors:  Rosiane Simeon; Omar Dewidar; Jessica Trawin; Stephanie Duench; Heather Manson; Jordi Pardo Pardo; Jennifer Petkovic; Janet Hatcher Roberts; Peter Tugwell; Manosila Yoganathan; Justin Presseau; Vivian Welch
Journal:  J Med Internet Res       Date:  2020-06-11       Impact factor: 5.428

10.  Effectiveness of Lifestyle Intervention for Type 2 Diabetes in Primary Care: the REAL HEALTH-Diabetes Randomized Clinical Trial.

Authors:  Linda M Delahanty; Douglas E Levy; Yuchiao Chang; Bianca C Porneala; Valerie Goldman; Jeanna McCarthy; Laurie Bissett; Anthony Romeo Rodriguez; Barbara Chase; Rajani LaRocca; Amy Wheeler; Deborah J Wexler
Journal:  J Gen Intern Med       Date:  2020-01-21       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.